EUVIMEDScopri EUVIMED
VergleichsstudieOpen access

Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study

Wing Lam Erica Fong iD, Vincent Grigori Nguyen iD, Sarah Beale iD, Thomas E Byrne iD, Cyril Geismar iD, Ellen Fragaszy iD, Jana Kovar iD, Alexei Yavlinsky iD, Ibrahim Abubakar iD, Andrew C Hayward iD, Robert W Aldridge iD

JMIR Public Health and Surveillance · 2025

DOI: 10.2196/69655 ↗

At a glance

Vergleichsstudie in JMIR Public Health and Surveillance, 2025. Written by Wing Lam Erica Fong and 10 co-authors. Institution: Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom, 44 02035495969. Major MEDLINE topics: COVID-19, Hospitalization, Population Surveillance. Cited 1 times so far (Crossref); 33 references. The full text is freely available in PubMed Central. Funded by: Wellcome Trust, Medical Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Effective disease surveillance is essential for understanding pathogens’ epidemiology, detecting outbreaks, and enabling timely public health responses. In the United Kingdom, large-scale studies, such as the Office for National Statistics COVID-19 Infection Survey (CIS), have monitored SARS-CoV-2 transmission but required significant resources, making them challenging to sustain when pandemic-specific funding ends and also in resource-limited settings. In contrast, the Virus Watch study, at lower cost, relied on self-reported and linked national testing data as well as symptomatic testing, while Severe Acute Respiratory Infections Watch (SARI) leveraged hospital data for cost-effective surveillance.

Objective

This study aimed to evaluate the effectiveness of Virus Watch as a surveillance system in monitoring COVID-19 positivity, incidence, and hospitalization rates in England and Wales, using data from the CIS and SARI as benchmarks for comparison, while considering the key differences in the study designs, including recruitment strategies, incentives, and testing criteria.

Methods

We used the Virus Watch prospective community cohort study to estimate COVID-19 positivity, incidence, and hospitalization rates in England and Wales from June 2020 to March 2023. Rate estimates were compared with CIS modeled positivity and incidence rates, and with SARI COVID-19 hospitalization rates. Global synchrony between datasets was measured using overall Spearman ⍴ and local synchrony using 9-week rolling Spearman ⍴. For England, comparisons with CIS estimates used Virus Watch rates calculated with and without linked national testing data. Positivity rates were also assessed overall and separately before and after the end of free national testing.

Results

A total of 58,628 participants were recruited into the Virus Watch study, of whom 52,526 (89.6%) were resident in England and 1532 (2.6%) in Wales; region was missing for the remainder. Virus Watch–estimated COVID-19 positivity and incidence rates in England, calculated with and without linked testing data, showed strong global synchrony with CIS estimates (positivity ⍴: 0.91 and 0.90; both P

Subjects

MeSH terms (MEDLINE)

COVID-19HospitalizationPopulation SurveillanceHumansIncidenceEnglandWalesSARS-CoV-2Prospective StudiesMiddle AgedFemaleMaleAdult

Author keywords

COVID-19SARS-CoV-2public health monitoringstudy comparisonsurveillance

Authors and institutions

  • Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, United Kingdom, 44 02035495969.
  • Institute of Epidemiology and Health Care, University College London, London, United Kingdom.
  • Department of Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • NIHR Health Protection Research Unit in Modelling and Health Economics, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
  • Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Faculty of Population Health Sciences, University College London, London, United Kingdom.

ORCID profiles: Wing Lam Erica Fong, Vincent Grigori Nguyen, Sarah Beale, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Jana Kovar, Alexei Yavlinsky, Ibrahim Abubakar, Andrew C Hayward, Robert W Aldridge

Funding

  • Wellcome Trust
  • Medical Research Council

Cite

APA

Fong, W. L. E., Nguyen, V. G., Beale, S., Byrne, T. E., Geismar, C., Fragaszy, E., Kovar, J., Yavlinsky, A., Abubakar, I., Hayward, A. C., & Aldridge, R. W. (2025). Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/69655

Vancouver

Fong WLE, Nguyen VG, Beale S, Byrne TE, Geismar C, Fragaszy E, et al. Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study. JMIR Public Health and Surveillance. 2025. doi:10.2196/69655

BibTeX
@article{Fong2025,
  author = {Fong, Wing Lam Erica and Nguyen, Vincent Grigori and Beale, Sarah and Byrne, Thomas E and Geismar, Cyril and Fragaszy, Ellen and Kovar, Jana and Yavlinsky, Alexei and Abubakar, Ibrahim and Hayward, Andrew C and Aldridge, Robert W},
  title = {Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2025},
  doi = {10.2196/69655}
}
Start for free →